Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Schmidt

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
International Journal of Molecular Sciences|October 23, 2021
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical DataRoberto Giugliani, Ana Maria Martins, Torayuki Okuyama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trialPaul Harmatz, Roberto Giugliani, Ana Maria Martins, et al.
Cellular & Molecular Immunology|March 29, 2025
Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotypeJagoda Agnieszka Szlachetko, Francisca Hofmann-Vega, Bettina Budeus, et al.
Molecular Metabolism|September 20, 2024
HDAC5 controls a hypothalamic STAT5b-TH axis, the sympathetic activation of ATP-consuming futile cycles and adult-onset obesity in male miceRaian E Contreras, Tim Gruber, Ismael González-García, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
International Journal of Molecular Sciences|October 23, 2021
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical DataRoberto Giugliani, Ana Maria Martins, Torayuki Okuyama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2024
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trialPaul Harmatz, Roberto Giugliani, Ana Maria Martins, et al.
Cellular & Molecular Immunology|March 29, 2025
Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotypeJagoda Agnieszka Szlachetko, Francisca Hofmann-Vega, Bettina Budeus, et al.
Molecular Metabolism|September 20, 2024
HDAC5 controls a hypothalamic STAT5b-TH axis, the sympathetic activation of ATP-consuming futile cycles and adult-onset obesity in male miceRaian E Contreras, Tim Gruber, Ismael González-García, et al.
Pageof 11